Snake venom metalloproteinases are predominantly responsible for the cytotoxic effects of certain African viper venoms

This article has been Reviewed by the following groups

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Abstract

Snakebite envenoming is a neglected tropical disease that causes substantial mortality and morbidity globally. The puff adder ( Bitis arietans ) and saw-scaled viper ( Echis romani ) have cytotoxic venoms that cause permanent injury via tissue-destructive dermonecrosis around the bite site. Identification of cytotoxic toxins within these venoms will allow development of targeted treatments, such as small molecule inhibitors or monoclonal antibodies to prevent snakebite morbidity. Venoms from both species were fractionated using gel filtration chromatography, and a combination of cell-based cytotoxicity approaches, SDS-PAGE gel electrophoresis, and enzymatic assays were applied to identify venom cytotoxins in the resulting fractions. Our results indicated that snake venom metalloproteinase (SVMP) toxins are predominately responsible for causing cytotoxic effects across both venoms, but that the PII subclass of SVMPs are likely the main driver of cytotoxicity following envenoming by B. arietans , whilst the structurally distinct PIII subclass of SVMPs are responsible for conveying this effect in E. romani venom. Identification of distinct SVMPs as the primary cytotoxicity-causing toxins in these two African viper venoms will facilitate the future design and development of novel therapeutics targeting these medically important venoms, which in turn could help to mitigate the severe life and limb threatening consequences of tropical snakebite.

Key Contribution

SVMP toxins were identified as the primary cytotoxicity-causing toxins in the venoms of the puff adder ( Bitis arietans ) and saw-scaled viper ( Echis romani ); PII and PIII SVMPs, respectively. This cytotoxicity can be prevented using the metalloproteinase-inhibiting chelator EDTA, suggesting targeted drugs/antibodies may be a viable option for future treatment.

Article activity feed

  1. Excerpt

    Understanding the cytotoxic mechanisms driving snakebite envenoming may help uncover new therapeutics and pharmacological agents.